Probi AB (OTCPK:PBBIF)
$ 24 0 (0%) Market Cap: 361.49 Mil Enterprise Value: 339.47 Mil PE Ratio: 361.46 PB Ratio: 2.89 GF Score: 72/100

Q4 2022 Probi AB Earnings Call Transcript

Jan 27, 2023 / 09:00AM GMT
Release Date Price: $18.9
Operator

Welcome to Probi Q4 Report 2022. (Operator Instructions)

Now I will hand the conference over to CEO, Anita Johansen; and CFO, Henrik Lundkvist. Please go ahead.

Anita Johansen;publ;Interim CEO and VP of R;D
Probi AB

()-&

Welcome and thank you for dialing in to Probi's presentation of our Q4 results for 2022. With me is Henrik Lundkvist, the CFO of Probi. And my name is Anita Johansen, I'm the Interim CEO of Probi since December last year.

Before commencing with the financial results, I'll provide a short background of my professional profile. I joined Probi in April 2022 as the VP of Research and Development. And this role, I'm maintaining in parallel with my current interim CEO role. My education is a Master in pharmacy and I've earned a PhD in pharmaceutical technology from the Danish University of Pharmaceutical Sciences, which is now the University of Copenhagen in Denmark. I have more than 20 years of experience from working in the consumer health care industry, housing senior

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investorsā€™ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot